Universal Cancer Hospital Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
as on 13-12-2024
- Paid Up Capital ₹ 22.39 Cr
as on 13-12-2024
- Company Age 10 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 13.52 Cr
as on 13-12-2024
- Satisfied Charges ₹ 13.06 Cr
as on 13-12-2024
- Revenue 16.73%
(FY 2022)
- Profit 513.48%
(FY 2022)
- Ebitda 72.31%
(FY 2022)
- Net Worth 37.83%
(FY 2022)
- Total Assets -7.88%
(FY 2022)
About Universal Cancer Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 22.39 Cr.
The company currently has active open charges totaling ₹13.52 Cr. The company has closed loans amounting to ₹13.06 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ganapathy Vijayakumar, Boopathi Jayaraman, Subramani Natarajan, and Five other members serve as directors at the Company.
- CIN/LLPIN
U85100TZ2014PLC032085
- Company No.
032085
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
17 Mar 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Salem, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Universal Cancer Hospital?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subramani Natarajan  | Managing Director | 31-Dec-2015 | Current |
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ganapathy Vijayakumar | Director | 14-Jan-2015 | Current |
| Boopathi Jayaraman | Director | 31-Dec-2015 | Current |
| Thirumalai Loganathan | Director | 03-Jun-2016 | Current |
| Karuppannan Manimaran | Director | 14-Jul-2016 | Current |
| Murugan | Director | 14-Jul-2016 | Current |
| Kandasamy Radhakrishnan | Director | 14-Jul-2016 | Current |
Financial Performance of Universal Cancer Hospital.
Universal Cancer Hospital Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 16.73% increase. The company also saw a substantial improvement in profitability, with a 513.48% increase in profit. The company's net worth Soared by an impressive increase of 37.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Universal Cancer Hospital?
In 2022, Universal Cancer Hospital had a promoter holding of 20.11% and a public holding of 79.89%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
K.K And Siddharth Finance Private LimitedActive 4 years 9 monthsKaruppannan Manimaran is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 07 Mar 2023 | ₹12.00 Cr | Open |
Hdfc Bank Limited Creation Date: 24 Mar 2022 | ₹1.52 Cr | Open |
Others Creation Date: 18 Jul 2016 | ₹5.00 Cr | Satisfied |
How Many Employees Work at Universal Cancer Hospital?
Universal Cancer Hospital has a workforce of 19 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Universal Cancer Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Universal Cancer Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
